you are viewing a single comment's thread.
Up 00.0%. Avg. of the ten big pharmasDn 00.1%. Avg. of PFE's nine big peersDn 00.3%. Avg. of the six domestic pharmasDn 00.6%. Avg. of PFE's five domestic peersUp 00.6%. Avg. of the four European pharmasUp 11.6%. S & P 500 (1,258 to 1,404)
This was the tenth week in 2012 where the big phrmas on balance underperformed the S & P 500. Only in the week ended March 2 did the big pharmas slightly outperform.The sector is very much out of favor this quarter with the group being flat while the S & P has had a major advance of 11.6%.